Erin Macrae - Concepedia

Author

Erin Macrae

The Ohio State University

Also Known As

E Macrae, Erin MacRae, Erin Macrae, Erin R Macrae, Erin R. Macrae, Erin Renee Macrae, Jennifer K. Litton

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University Columbus Oncology and Hematology Associates The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute The University of Texas MD Anderson Cancer Center National Cancer Institute

About

Erin Macrae is an author at The Ohio State University specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	200
2	Pathology	4	4	123
3	Immunology	3	3	106
4	Cell Biology	2	2	50
5	Allergy Medicine	1	1	27

Erin Macrae

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline Hope S. Rugo, R. Bryan Rumble, Erin Macrae, Journal of Clinical Oncology	2016	623
Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF<sup>V600E</sup></i> Mutations: Results of the NCI-MATCH Trial Subprotocol H April K.S. Salama, Shuli Li, Erin Macrae, Journal of Clinical Oncology	2020	277
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients Maryam B. Lustberg, Priya Balasubramanian, Brandon Miller, Breast Cancer Research	2014	120
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer Robert Wesolowski, Megan Duggan, Andrew Stiff, Cancer Immunology Immunotherapy Breast OncologyMedicineImmunologyPathologyNeo-adjuvant Chemotherapy	2017	71
Use and Duration of Chemotherapy in Patients With Metastatic Breast Cancer According to Tumor Subtype and Line of Therapy Davinia Seah, Inês Vaz-Luís, Erin Macrae, Journal of the National Comprehensive Cancer Network	2014	47
Noncatalytic <i>PTEN</i> missense mutation predisposes to organ-selective cancer development in vivo Enrico Caserta, Onur Egriboz, Hui Wang, Genes & Development	2015	32
Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation Huayang Liu, James A. Dowdle, Safiya Khurshid, Developmental Cell Signal TransductionSignaling PathwayCell RegulationStromal Regulatory NetworksCellular Regulatory Mechanism	2017	29
Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction Michael Berger, Craig Vargo, M J Vincent, Supportive Care in Cancer Drug HypersensitivityOncologyAllergy MedicineMedicinePharmacology	2014	27
BRAF mutations in melanocytic lesions and papillary thyroid carcinoma samples identified using melting curve analysis of polymerase chain reaction products. Robert W. Hay, Erin Macrae, Duane Barber, PubMed	2007	21
JUNB promotes the survival of Flavopiridol treated human breast cancer cells Mellissa Hicks, Qiuping Hu, Erin Macrae, Biochemical and Biophysical Research Communications Tumor BiologyBreast OncologyChemoprevention StrategyMedicinePharmacology	2014	21

Page 1